Cost-effectiveness of targeted screening for hepatitis C in The Netherlands (original) (raw)
Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands
Clary van der Veen
International Journal of Drug Policy, 2017
View PDFchevron_right
HCV Screening to Enable Early Treatment of Hepatitis C: A athematical Model to Analyse Costs and Outcomes in Two Populations
Andrea Tramarin
Current Pharmaceutical Design, 2008
View PDFchevron_right
The testing of people with any risk factor for hepatitis C in community pharmacies is cost‐effective
ryan buchanan
Journal of Viral Hepatitis, 2019
View PDFchevron_right
Economic evaluation of screening programs for hepatitis C virus infection: evidence from literature
Silvia Coretti
Risk Management and Healthcare Policy, 2015
View PDFchevron_right
Assessing the cost-effectiveness of hepatitis C screening strategies in France
Sylvie Deuffic-Burban
Journal of Hepatology, 2018
View PDFchevron_right
Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults
mendel singer
The American Journal of Medicine, 2001
View PDFchevron_right
Uptake of Hepatitis C Screening, Characteristics of Patients Tested, and Intervention Costs in the BEST-C Study
Joseph Kannry
Hepatology, 2016
View PDFchevron_right
Economic consequences of the implementation of national screening program for chronic HCV infection
Guenka Petrova
Expert Review of Pharmacoeconomics & Outcomes Research, 2019
View PDFchevron_right
Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States
Susana Williams Keeshin
JAMA Network Open, 2020
View PDFchevron_right
Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands
Peter ter Horst
European Journal of Health Economics, 2020
View PDFchevron_right
Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens
Mark Eckman
Clinical Gastroenterology and Hepatology, 2019
View PDFchevron_right
Eradicating hepatitis C: Are novel screening strategies for people who inject drugs cost-effective?
francesco manca
International Journal of Drug Policy, 2020
View PDFchevron_right
Screening for Hepatitis C in injecting drug users: a cost utility analysis
Kim Dalziel
Journal of Public Health, 2004
View PDFchevron_right
Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States
Mark Eckman
Clinical Infectious Diseases, 2013
View PDFchevron_right
Screening for hepatitis C in genito-urinary medicine clinics: a cost utility analysis
Kim Dalziel
Journal of Hepatology, 2003
View PDFchevron_right
Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?
David Prince
Canadian Journal of Gastroenterology and Hepatology
View PDFchevron_right
Case finding for hepatitis C in primary care: a cost utility analysis
Emanuela Castelnuovo
Family Practice, 2006
View PDFchevron_right
Economic model of a birth cohort screening program for hepatitis C virus
Lisa McGarry
Hepatology, 2012
View PDFchevron_right
Estimation of average diagnosis and treatment costs of hepatitis C
Azadeh Safaee
Gastroenterology and Hepatology from bed to bench, 2012
View PDFchevron_right
A Stepwise Approach to a National Hepatitis C Screening Strategy in Malaysia to Meet the WHO 2030 Targets: Proposed Strategy, Coverage, and Costs
Rosmawati Mohamed
Value in Health Regional Issues, 2019
View PDFchevron_right
Cost-effectiveness model for hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalence
Ahmed M Hablas
Global public health, 2014
View PDFchevron_right
Is Adding HCV Screening to the Antenatal National Screening Program in Amsterdam, The Netherlands, Cost-Effective?
Marjolijn van Keep
2016
View PDFchevron_right
Identification of Hidden Key Hepatitis C Populations: An Evaluation of Screening Practices Using Mixed Epidemiological Methods
Nicole Dukers-muijrers
PLoS ONE, 2012
View PDFchevron_right
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Colm Bergin
BMC Infectious Diseases, 2015
View PDFchevron_right
Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost-effectiveness model
AYAT R . ABDALLAH
View PDFchevron_right
Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era
Sergio Iannazzo
Alimentary Pharmacology & Therapeutics, 2019
View PDFchevron_right
Optimizing Implementation of Hepatitis C Birth-Cohort Screening and Treatment Strategies
Zelda Zabinsky
MDM Policy & Practice, 2017
View PDFchevron_right
Costing analysis of field implementation of hepatitis C case detection in rural Maung Russey operational district, Cambodia
jean-philippe dousset
Western Pacific Surveillance and Response, 2021
View PDFchevron_right
Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment
Eid Mansour
2021
View PDFchevron_right